| The role of CCND1 alterations during the progression of cutaneous malignant melanoma L Vízkeleti, S Ecsedi, Z Rákosy, A Orosz, V Lázár, G Emri, V Koroknai, ... Tumor Biology 33, 2189-2199, 2012 | 59 | 2012 |
| DNA hypermethylation is associated with invasive phenotype of malignant melanoma V Koroknai, I Szász, H Hernandez‐Vargas, N Fernandez‐Jimenez, ... Experimental dermatology 29 (1), 39-50, 2020 | 38 | 2020 |
| DNA methylation characteristics of primary melanomas with distinct biological behaviour S Ecsedi, H Hernandez-Vargas, SC Lima, L Vizkeleti, R Toth, V Lazar, ... PloS one 9 (5), e96612, 2014 | 34 | 2014 |
| The role of osteopontin expression in melanoma progression T Kiss, S Ecsedi, L Vizkeleti, V Koroknai, G Emri, N Kovács, R Adany, ... Tumor Biology 36, 7841-7847, 2015 | 31 | 2015 |
| Altered integrin expression patterns shown by microarray in human cutaneous melanoma L Vizkeleti, T Kiss, V Koroknai, S Ecsedi, O Papp, I Szasz, R Adany, ... Melanoma research 27 (3), 180-188, 2017 | 26 | 2017 |
| Molecular alterations associated with acquired resistance to BRAFV600E targeted therapy in melanoma cells I Szász, V Koroknai, T Kiss, L Vízkeleti, R Ádány, M Balázs Melanoma research 29 (4), 390-400, 2019 | 24 | 2019 |
| Genomic profiling of invasive melanoma cell lines by array comparative genomic hybridization V Koroknai, S Ecsedi, L Vízkeleti, T Kiss, I Szász, A Lukács, O Papp, ... Melanoma research 26 (2), 100-107, 2016 | 16 | 2016 |
| Gene expression signature of BRAF inhibitor resistant melanoma spheroids V Koroknai, V Patel, I Szász, R Ádány, M Balazs Pathology & Oncology Research 26 (4), 2557-2566, 2020 | 12 | 2020 |
| Silencing osteopontin expression inhibits proliferation, invasion and induce altered protein expression in melanoma cells T Kiss, K Jámbor, V Koroknai, I Szász, H Bárdos, A Mokánszki, R Ádány, ... Pathology and Oncology Research 27, 2021 | 11 | 2021 |
| Molecular alterations associated with acquired drug resistance during combined treatment with encorafenib and binimetinib in melanoma cell lines V Patel, I Szász, V Koroknai, T Kiss, M Balázs Cancers 13 (23), 6058, 2021 | 8 | 2021 |
| Cell proliferation is strongly associated with the treatment conditions of an er stress inducer new anti-melanoma drug in melanoma cell lines I Szász, V Koroknai, V Patel, T Hajdú, T Kiss, R Ádány, M Balázs Biomedicines 9 (2), 96, 2021 | 8 | 2021 |
| Cytokine and chemokine receptor patterns of human malignant melanoma cell lines V Koroknai, I Szász, K Jámbor, M Balázs International Journal of Molecular Sciences 23 (5), 2644, 2022 | 5 | 2022 |
| Identification of liquid biopsy-based mutations in colorectal cancer by targeted sequencing assays I Szász, T Kiss, A Mokánszki, V Koroknai, J Deák, V Patel, K Jámbor, ... Molecular and Cellular Probes 67, 101888, 2023 | 4 | 2023 |
| Gene expression patterns of Osteopontin isoforms and Integrins in malignant melanoma K Jámbor, V Koroknai, T Kiss, I Szász, P Pikó, M Balázs Pathology and Oncology Research 28, 2022 | 4 | 2022 |
| Gene expression changes in cytokine and chemokine receptors in association with melanoma liver metastasis V Koroknai, I Szász, M Balázs International Journal of Molecular Sciences 24 (10), 8901, 2023 | 3 | 2023 |
| Detection of CCND1 locus amplification by fluorescence in situ hybridization M Balázs, V Koroknai, I Szász, S Ecsedi The Retinoblastoma Protein, 85-100, 2018 | 3 | 2018 |
| Identification of Plasma Lipid Alterations Associated with Melanoma Metastasis I Szász, V Koroknai, T Várvölgyi, L Pál, S Szűcs, P Pikó, G Emri, E Janka, ... International Journal of Molecular Sciences 25 (8), 4251, 2024 | 2 | 2024 |
| Combining Biomarkers for the Diagnosis of Metastatic Melanoma T Várvölgyi, EA Janka, I Szász, V Koroknai, T Toka-Farkas, IL Szabó, ... Journal of Clinical Medicine 13 (1), 174, 2023 | 1 | 2023 |
| Expression pattern of osteopontin isoforms in malignant melanoma cell lines V Koroknai, I Szász, K Jámbor, M Balázs Clinical and Translational Science 17 (1), e13694, 2024 | | 2024 |
| Genomic alterations of invasive melanoma cells V Koroknai Magyar Onkologia 66 (3), 243-245, 2022 | | 2022 |
